XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
C
C

Corteva


Actualités

U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly

U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly June 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday. HIGHLIGHTS * Alimera Sciences Inc ALIM.O : Craig-Hallum cuts to hold from buy * Comtech Telecommunications Corp CMTL.O : Jefferies raises to hold from underperform * Eli Lilly LLY.N : Truist Securities raises targe
A
A
E
D
U
V
A
B
C
C
C
F
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
C
C
D
M

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
K
M
N
U
T
C
C
D
M

Some of the biggest splits in Corporate America

FACTBOX-Some of the biggest splits in Corporate America Adds DuPont, Masimo Corp, Lionsgate, Citigroup, Edwards Lifesciences, Western Digital and AT&T ; Updates Labcorp, 3M, Kellogg, J&J and General Electric Co May 23 (Reuters) - Chemical maker DuPont DD.N has become the latest multinational to break up its business, announcing a plan to split the firm into three publicly traded companies.
A
C
E
K
P
W
D
C
L
O

DuPont’s big breakup could be second-time lucky

BREAKINGVIEWS-DuPont’s big breakup could be second-time lucky The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Jonathan Guilford NEW YORK, May 23 (Reuters Breakingviews) - How big should a company be? For DuPont de Nemours DD.N boss Ed Breen, the real question is: how small? DuPont is about to break up into three companies, separating out its water and electronics units from the business that makes industrial materials such as Kevlar.
X
C
C
I

DuPont to split into three companies, replaces CEO Ed Breen

UPDATE 2-DuPont to split into three companies, replaces CEO Ed Breen Adds details throughout, updates shares in paragraph 1 May 22 (Reuters) - DuPont DD.N said on Wednesday it will split into three publicly traded companies, sending its shares up 5% after the bell as it joins a slew of U.S. conglomerates looking to unlock value and pursue focused growth.
C

BASF to pay $316 million to settle PFAS 'forever chemicals' US lawsuit

UPDATE 1-BASF to pay $316 million to settle PFAS 'forever chemicals' US lawsuit Adds details, context throughout By Clark Mindock May 21 (Reuters) - German chemical company BASF BASFn.DE said on Tuesday it reached a $316.5 million settlement with some U.S. public water systems that claimed toxic “forever chemicals” in firefighting foam made by the company contaminated their water supplies.
B
C

Ag inputs sales seen at good level in the US, not as good in South America

Ag inputs sales seen at good level in the US, not as good in South America By Marcelo Teixeira NEW YORK, May 16 (Reuters) - Sales of agricultural inputs such as fertilizers and crop care products have been near normal in the United States despite lower grain prices, while they are not as good in South America, according to agricultural input producers.
B
C

U.S. Berkshire Hathaway, Parker-Hannifin, Quaker Houghton

U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Parker-Hannifin, Quaker Houghton May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Berkshire Hathaway, Parker-Hannifin and Quaker Houghton, on Monday. HIGHLIGHTS * Berkshire Hathaway BRKa.N : KBW raises target price to $660,000 from $645,000 * Essex Property Trust Inc ESS.N : Piper Sandler raises target price to $315 from $291 * Parker-Hannifin Corp PH.N : Jefferies cuts
A
C
E
G
E
C
C

Corteva Inc reports results for the quarter ended in March - Earnings Summary

Corteva Inc reports results for the quarter ended in March - Earnings Summary Corteva Inc CTVA.N reported quarterly adjusted earnings of 89 cents​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $1.16. The mean expectation of nineteen analysts for the quarter was for earnings of 84 cents per share.
C

Corteva beats estimates for quarterly profit on strong seed sales

UPDATE 2-Corteva beats estimates for quarterly profit on strong seed sales Adds shares in paragraph 3, details and background in paragraphs 5-9 May 1 (Reuters) - Agrichemicals firm Corteva CTVA.N beat estimates for first-quarter profit on Wednesday, as strong performance in its North American seed business offset weakness in its crop protection u nit .
D
C

Corteva beats estimates for quarterly profit

Corteva beats estimates for quarterly profit May 1 (Reuters) - Agrichemicals firm Corteva CTVA.N beat market estimates for first-quarter profit on Wednesday, aided by strong seed sales in North America. The Indianapolis-based company reported operating earnings of 89 cents per share for the three months ended March 31, compared with analysts' estimate of 84 cents per share, according to LSEG data.
C

Corteva Outlook FY EBITDA Growth 6%

BRIEF-Corteva Outlook FY EBITDA Growth 6% May 01 (Reuters) - Corteva outlook FY EBITDA USD 3,500-3,700 million. outlook FY revenue USD 17,400-17,700 million outlook FY EPS USD 2.7-2.9
C

U.S. Air Products and Chemicals, Geron, PayPal

U.S. RESEARCH ROUNDUP- Air Products and Chemicals, Geron, PayPal May 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Air Products and Chemicals, Geron and PayPal, on Wednesday. HIGHLIGHTS * 3M Co MMM.N : RBC raises target price to $87 from $78 * Air Products and Chemicals Inc APD.N : TD Cowen raises target price to $320 from $305 * Crescent Energy Co CRGY.N : Gerdes Energy Research raises to buy from neutral * Gero
A
P
A
A
C
D
A
E
C
C
C

What to Watch in the Day Ahead - Wednesday, May 1

What to Watch in the Day Ahead - Wednesday, May 1 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT U.S. Federal Reserve's Federal Open Market Committee (FOMC) announces its decision on interest rates.
C
E
M
M
P
Q
Q
T
V
K
E
G
C

Corteva Inc <CTVA.N> expected to post earnings of 84 cents a share - Earnings Preview

Corteva Inc expected to post earnings of 84 cents a share - Earnings Preview Corteva Inc CTVA.N , CTVA.K is expected to show a fall in quarterly revenue when it reports results on May 1 for the period ending March 31 2024 The Indianapolis Indiana-based company is expected to report a 4.9% decrease in revenue to $4.646 billion from $4.88 billion a year ago, according to the mean estimate from 17 analysts, based on LSEG data.
C

Agrochemicals company Syngenta posts big drop in Q1 sales, earnings

UPDATE 1-Agrochemicals company Syngenta posts big drop in Q1 sales, earnings Adds details, background ZURICH, April 29 (Reuters) - Seeds and pesticides maker Syngenta suffered big drops in first quarter sales and profit, the company said on Monday, just a few weeks after the Swiss company shelved its plans for a $10 billion flotation. Sales fell 20% to $7.4 billion, Syngenta said, while core operating profit (EBITDA) declined by 34% to $1.2 billion, as farmers continued to run down their supplie
B
B
C

Corteva Announces Its Board Of Directors Has Authorized A Dividend Of $0.16 Per Share

BRIEF-Corteva Announces Its Board Of Directors Has Authorized A Dividend Of $0.16 Per Share April 26 (Reuters) - Corteva Inc CTVA.N : CORTEVA INC: ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED A COMMON STOCK DIVIDEND OF $0.16 CENTS PER SHARE Source text for Eikon: ID:nPn15Fc6Ka Further company coverage: CTVA.N
C

Lawyers in PFAS water pollution settlements win $956 mln fee award

Lawyers in PFAS water pollution settlements win $956 mln fee award By Clark Mindock April 23 (Reuters) - A U.S. judge on Tuesday awarded over $956 million in legal fees to plaintiffs’ lawyers who secured two settlements worth more than $11 billion with major manufacturers of toxic “forever chemicals” on behalf of public water systems. U.S. District Judge Richard Gergel in Charleston, South Carolina, granted unopposed fee requests after 3M MMM.N , DuPont de Nemours Inc DD.N , Chemours CC.N
C

U.S. Advanced Micro Devices, Kroger, Tyson Foods

U.S. RESEARCH ROUNDUP-Advanced Micro Devices, Kroger, Tyson Foods April 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advanced Micro Devices, Kroger and Tyson Foods, on Tuesday. HIGHLIGHTS * Advanced Micro Devices Inc AMD.O : HSBC raises to buy * CNO Financial Group Inc CNO.N : Piper Sandler raises to overweight from neutral * Endeavor Group Holdings Inc EDR.N : Citigroup cuts to neutral from buy * Kroger Co KR.
A
A
B
B
C
C
G
G
I
N
S
A
A
K
L
A
C
C
C
M



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques